1921
Volume 101, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

We report the case of a 64-year-old woman found to have urban-acquired () human African trypanosomiasis (HAT) as the cause of sustained fever starting 9 months after returning to Canada from Democratic Republic of the Congo, in the context of concomitant multiple myeloma and HIV-1 coinfection. Approaches for the management of both clinical stages of HAT are well defined for endemic settings using current diagnostics and treatments. However, few data inform the diagnosis and management of patients with bone marrow suppression from active malignancy, recent anticancer therapy, or HIV coinfection. We discuss the implications of immunosuppression for diagnosis and management of HAT.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0889
2019-05-06
2020-09-28
Loading full text...

Full text loading...

/deliver/fulltext/14761645/101/1/tpmd180889.html?itemId=/content/journals/10.4269/ajtmh.18-0889&mimeType=html&fmt=ahah

References

  1. WHO, 2013. Control and Surveillance of Human African Trypanosomiasis. Geneva, Switzerland: World Health Organization.
    [Google Scholar]
  2. Chappuis F, Loutan L, Simarro P, Lejon V, Büscher P, 2005. Options for field diagnosis of human African trypanosomiasis. Clin Microbiol Rev 18: 133146.
    [Google Scholar]
  3. Büscher P, Mumba Ngoyi D, Kaboré J, Lejon V, Robays J, Jamonneau V, Bebronne N, Van der Veken W, Biéler S, 2009. Improved models of mini anion exchange centrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl Trop Dis 3: e471.
    [Google Scholar]
  4. Franco JR, Cecchi G, Priotto G, Paone M, Diarra A, Grout L, Simarro PP, Zhao W, Argaw D, 2018. Monitoring the elimination of human African trypanosomiasis: update to 2016. PLoS Negl Trop Dis 12: e0006890.
    [Google Scholar]
  5. Robays J, Ebeja Kadima A, Lutumba P, Miaka mia Bilenge C, Kande Betu Ku Mesu V, De Deken R, Makabuza J, Deguerry M, Van der Stuyft P, Boelaert M, 2004. Human African trypanosomiasis amongst urban residents in Kinshasa: a case-control study. Trop Med Int Heal 9: 869875.
    [Google Scholar]
  6. Simon F, Mura M, Pagès F, Morand G, Truc P, Louis F, Gautret P, 2012. Urban transmission of human African trypanosomiasis, Gabon. Emerg Infect Dis 18: 165167.
    [Google Scholar]
  7. Leder K et al., GeoSentinel Surveillance Network, 2013. GEosentinel surveillance of illness in returned travelers, 2007–2011. Ann Intern Med 158: 456468.
    [Google Scholar]
  8. Simarro PP, Franco JR, Cecchi G, Paone M, Diarra A, Ruiz Postigo JA, Jannin JG, 2012. Human African trypanosomiasis in non-endemic countries (2000–2010). J Travel Med 19: 4453.
    [Google Scholar]
  9. Brun R, Blum J, Chappuis F, Burri C, 2010. Human African trypanosomiasis. Lancet 375: 148159.
    [Google Scholar]
  10. Büscher P, Cecchi G, Jamonneau V, Priotto G, 2017. Human African trypanosomiasis. Lancet 390: 23972409.
    [Google Scholar]
  11. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, Keystone JS, Pandey P, Cetron MS, 2006. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354: 119130.
    [Google Scholar]
  12. Mukendi D et al., 2017. Clinical spectrum, etiology, and outcome of neurological disorders in the rural hospital of Mosango, the Democratic Republic of Congo. Am J Trop Med Hyg 97: 14541460.
    [Google Scholar]
  13. Rajkumar SV, 2011. Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management. Am J Hematol 87: 7888.
    [Google Scholar]
  14. Sudarshi D et al., 2014. Human African trypanosomiasis presenting at least 29 years after infection—what can this teach us about the pathogenesis and control of this neglected tropical disease? PLoS Negl Trop Dis 8: e3349.
    [Google Scholar]
  15. Pays E, 2005. Regulation of antigen gene expression in Trypanosoma brucei. Trends Parasitol 21: 517520.
    [Google Scholar]
  16. Meda HA, Doua F, Laveissière C, Miezan TW, Gaens E, Brattegaard K, de Muynck A, De Cock KM, 1995. Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d’Ivoire. Trans R Soc Trop Med Hyg 89: 639643.
    [Google Scholar]
  17. Perez CJ, Lymbery AJ, Thompson RCA, 2015. Reactivation of Chagas disease: implications for global health. Trends Parasitol 31: 595603.
    [Google Scholar]
  18. Diro E, Lynen L, Ritmeijer K, Boelaert M, Hailu A, van Griensven J, 2014. Visceral leishmaniasis and HIV coinfection in east Africa. PLoS Negl Trop Dis 8: e2869.
    [Google Scholar]
  19. Sartori AMC, Lopes MH, Caramelli B, Duarte MIS, Pinto PL, Neto V, Amato Shikanai-Yasuda M, 1995. Simultaneous occurrence of acute myocarditis and reactivated Chagas’ disease in a patient with AIDS. Clin Infect Dis 21: 12971299.
    [Google Scholar]
  20. Cordova E, Boschi A, Ambrosioni J, Cudos C, Corti M, 2008. Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992–2007. Int J Infect Dis 12: 587592.
    [Google Scholar]
  21. Truc P, Lejon V, Magnus E, Jamonneau V, Nangouma A, Verloo D, Penchenier L, Büscher P, 2002. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in west and central Africa. Bull World Health Organ 80: 882886.
    [Google Scholar]
  22. Simarro PP, Ruiz JA, Franco JR, Josenando T, 2002. Attitude towards CATT-positive individuals without parasitological confirmation in the African trypanosomiasis (T.b. gambiense) focus of Quiçama (Angola). Trop Med Int Health 4: 858861.
    [Google Scholar]
  23. Boelaert M et al., 2017. A phase III diagnostic accuracy study of a rapid diagnostic test for diagnosis of second stage human African trypanosomiasis in the Democratic Republic of the Congo. EBioMedicine 27: 1117.
    [Google Scholar]
  24. Lejon V, Boelaert M, Jannin J, Moore A, Büscher P, 2003. The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa. Lancet Infect Dis 3: 804808.
    [Google Scholar]
  25. Garcia A, Jamonneau V, Magnus E, Laveissière C, Lejon V, N’guessan P, N’Dri L, Van Meirvenne N, Büscher P, 2008. Follow-up of card agglutination trypanosomiasis test (CATT) positive but apparently aparasitaemic individuals in Côte d’Ivoire: evidence for a complex and heterogeneous population. Trop Med Int Health 5: 786793.
    [Google Scholar]
  26. Nkemgu-Njinkeng J, Rosenkranz V, Wink M, Steverding D, 2002. Antitrypanosomal activities of proteasome inhibitors. Antimicrob Agents Chemother 46: 20382040.
    [Google Scholar]
  27. Steverding D, Wang X, 2009. Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib. Parasit Vectors 2: 29.
    [Google Scholar]
  28. Barrett SV, Barrett MP, 2000. Anti-sleeping sickness drugs and cancer chemotherapy. Parasitol Today 16: 79.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0889
Loading
/content/journals/10.4269/ajtmh.18-0889
Loading

Data & Media loading...

  • Received : 06 Nov 2018
  • Accepted : 16 Mar 2019
  • Published online : 06 May 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error